The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Dyne Therapeutics Appoints Doug Kerr As Chief Medical Officer and Johanna Friedl Naderer As Chief Commercial Officer
PUBLIC · DYNSep 03, 2024•almost 2 years ago
Position
Chief Commercial Officer
Company
Dyne Therapeutics
Johanna Friedl-Naderer
WalthamBiotechnologyHealth CareTherapeutics
Description
Dyne Therapeutics has announced the appointment of Doug Kerr as chief medical officer, succeeding Wildon Farwell, and Johanna Friedl-Naderer as chief commercial officer. Additionally, Lucia Celona has been appointed as chief human resources officer.
Company Information
Company
Dyne Therapeutics
Location
Waltham, Massachusetts, United States
About
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities.
WalthamBiotechnologyHealth CareTherapeutics